Related Experiment Video
Updated: Oct 21, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Congenital and Perinatal Tuberculosis
Yi Shao1, Joseph R Hageman2, Stanford T Shulman3
1Department of Pediatrics and.
Insights
Congenital or perinatal tuberculosis (TB) in infants requires prompt diagnosis and treatment. Early suspicion and management of neonatal TB can prevent severe complications and reduce mortality.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Pediatric Pulmonology
Background:
- Congenital or perinatal tuberculosis (TB) is rare but serious in neonates.
- Diagnosis is often delayed, leading to poor outcomes.
- Literature from 2006-2020 highlights diagnostic and management challenges.
Purpose of the Study:
- To review the epidemiology, clinical presentation, diagnosis, and management of congenital/perinatal TB in infants.
- To provide clear recommendations for evaluation and treatment.
- To emphasize early recognition and intervention.
Main Methods:
- Comprehensive literature review (2006-2020).
- Analysis of case reports and epidemiological data.
- Synthesis of clinical guidelines and expert recommendations.
Main Results:
- Neonatal TB diagnosis is often missed, with suspicion arising only after poor response to antibiotics.
- Delayed treatment increases the need for cardiopulmonary support and mortality risk.
- Key maternal and infant history elements are crucial for early suspicion.
Conclusions:
- Early suspicion of neonatal TB is critical, especially in high-risk infants.
- Prompt initiation of anti-TB therapy is essential for improved outcomes.
- Standardized evaluation and follow-up protocols are needed for infants with suspected TB.
Abstract:
This review discusses the recent literature (2006-2020) about the epidemiology, clinical presentation, diagnosis, and management of infants with congenital or perinatal tuberculosis (TB). While the incidence of childhood TB is declining in the United States and worldwide, many case reports describe how clinical suspicion for neonatal TB is raised only if an ill-appearing neonate does not improve with broad-spectrum antibiotics. Furthermore, the delay in initiating appropriate anti-TB therapy often results in the need for significant cardiopulmonary support and/or an increase in mortality. This review summarizes important clinical indications in the maternal and newborn history, the evaluation of an infant with possible TB exposure, and step-by-step recommendations for the treatment and follow-up of infants with TB.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Other Pulmonary Disorders

